UPDATED Feb 16, 2024
All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
EPNEpsilon Healthcare | AU$0.024 | 0% | 4.3% | AU$7.2m | n/a | PB0.8x | n/a | n/a | ||
ILAIsland Pharmaceuticals | AU$0.083 | -3.5% | -30.8% | AU$6.7m | n/a | PS609.6x | E4.9% | n/a | ||
IXCInvex Therapeutics | AU$0.085 | 3.7% | -83.0% | AU$6.4m | n/a | PS156.3x | n/a | n/a | ||
CGBCann Global | AU$0.021 | 0% | -72.0% | AU$5.4m | n/a | PS9.7x | n/a | n/a | ||
NSBNeuroScientific Biopharmaceuticals | AU$0.037 | -9.8% | -59.3% | AU$5.4m | n/a | PS1.1x | n/a | n/a | ||
EX1Exopharm | AU$0.011 | 0% | -81.7% | AU$4.8m | n/a | PS1.4x | n/a | n/a | ||
NC6Nanollose | AU$0.025 | 4.2% | -56.9% | AU$4.3m | n/a | PS10.4x | n/a | n/a | ||
BODBod Science | AU$0.024 | 0% | -65.2% | AU$4.3m | n/a | PS1.3x | n/a | n/a | ||
ANRAnatara Lifesciences | AU$0.024 | 0% | -29.4% | AU$4.0m | n/a | PB4.4x | n/a | n/a | ||
ME1Melodiol Global Health | AU$0.014 | -6.7% | -95.9% | AU$3.7m | n/a | PB0.4x | n/a | n/a | ||
NYRNyrada | AU$0.02 | -4.8% | -84.0% | AU$3.1m | n/a | PS2.2x | n/a | n/a | ||
VTLVGI Health Technology | AU$0.02 | 0% | n/a | AU$2.8m | n/a | PS112.4x | n/a | n/a | ||
HXLHexima | AU$0.015 | 7.1% | -11.8% | AU$2.5m | n/a | PS1.7x | n/a | n/a | ||
RGSRegeneus | AU$0.006 | 0% | -50.0% | AU$1.8m | n/a | PS1.8x | n/a | n/a | ||
BP8BPH Global | AU$0.001 | -33.3% | n/a | AU$1.8m | n/a | PS5414.6x | n/a | n/a | ||
WFLWellfully | AU$0.003 | 0% | -87.0% | AU$1.5m | n/a | PE-0.2x | n/a | n/a |